Peter Vanacker
Overview
Explore the profile of Peter Vanacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
918
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kneihsl M, Hakim A, Goeldlin M, Meinel T, Branca M, Rohner R, et al.
Neurology
. 2024 Dec;
104(1):e210157.
PMID: 39700448
Background And Objectives: Covert brain infarcts (CBIs) in patients with first-ever ischemic stroke (IS) and atrial fibrillation (AF) are associated with an increased risk of stroke recurrence. We aimed to...
2.
Vandelanotte S, Staessens S, Francois O, De Wilde M, Desender L, De Sloovere A, et al.
J Thromb Haemost
. 2024 Jun;
22(9):2555-2561.
PMID: 38897388
Background: Achieving first-pass recanalization (FPR) has become the primary procedural objective during thrombectomy in acute ischemic stroke patients as it correlates with the best clinical outcome. Understanding factors contributing to...
3.
Cancelloni V, Buratti M, Tsivgoulis G, Furie K, Tadi P, Caso V, et al.
Neurol Sci
. 2024 May;
45(10):4895-4902.
PMID: 38775860
Background: Intravenous thrombolysis (IVT) and/or endovascular therapy (EVT) are currently considered best practices in acute stroke patients. Data regarding the efficacy and safety of reperfusion therapies in patients with atrial...
4.
Vandelanotte S, Francois O, Desender L, Staessens S, Vanhoorne A, Van Gool F, et al.
Stroke
. 2024 Mar;
55(5):1181-1190.
PMID: 38525646
Background: Resistance to r-tPA (recombinant tissue-type plasminogen activator) is a well-known but poorly understood phenomenon that hampers successful recanalization in patients with acute ischemic stroke. Using clinically relevant thrombi from...
5.
Gruwez H, Verbrugge F, Proesmans T, Evens S, Vanacker P, Rutgers M, et al.
Eur Heart J Digit Health
. 2023 Dec;
4(6):464-472.
PMID: 38045439
Aims: The aim of this study is to determine the feasibility, detection rate, and therapeutic implications of large-scale smartphone-based screening for atrial fibrillation (AF). Methods And Results: Subjects from the...
6.
Paciaroni M, Caso V, Romoli M, Becattini C, Salerno A, Rapillo C, et al.
Eur Stroke J
. 2023 Jul;
8(4):1030-1040.
PMID: 37452632
Introduction: The best therapeutic strategy for patients with mechanical heart valves (MHVs) having acute ischemic stroke during treatment with vitamin K antagonists (VKAs) remain unclear. Being so, we compared the...
7.
Steenkamer B, Vaes B, Rietzschel E, Crombez J, de Geest S, Demeure F, et al.
BMC Health Serv Res
. 2023 Jun;
23(1):659.
PMID: 37340416
Background: Although there are already success stories, population health management in Belgium is still in its infancy. A health system transformation approach such as population health management may be suited...
8.
Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S, et al.
N Engl J Med
. 2023 May;
388(26):2411-2421.
PMID: 37222476
Background: The effect of early as compared with later initiation of direct oral anticoagulants (DOACs) in persons with atrial fibrillation who have had an acute ischemic stroke is unclear. Methods:...
9.
Vantyghem S, Staessens S, Francois O, De Meyer S, Vanacker P
Acta Neurol Belg
. 2023 Apr;
123(3):1201-1203.
PMID: 37040065
No abstract available.
10.
De Moerloose S, Geerts P, Vanacker P, Lemmens G
J ECT
. 2022 Nov;
38(4):260-261.
PMID: 36417415
No abstract available.